Tao Xu
-
- Neuroscience and Neuropharmacology Research 13
- Neuropeptides and Animal Physiology 8
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 5
- Cancer Research top 10%
-
- Pain Mechanisms and Treatments 21
-
- Ion channel regulation and function 9
- Receptor Mechanisms and Signaling 5
-
- Musculoskeletal pain and rehabilitation 5
-
- Cancer Immunotherapy and Biomarkers 4
- Co-authors
- Weijun XuanYing‐Ying HuangTakahiro AndoMichael R. HamblinQiuhe WuSulbha K. SharmaMichael J. WhalenTianhong Dai
- Journals
- SHILAP Revista de lepidopterología (5 papers)PLoS ONE (3 papers)Development (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Tao Xu
111 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 142
- Radiology, Nuclear Medicine and Imaging 429
- Cellular and Molecular Neuroscience 276
- Neurology 102
- Cancer Research 182
- Biological Psychiatry 27
Countries citing papers authored by Tao Xu
This map shows the geographic impact of Tao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Xu more than expected).
Fields of papers citing papers by Tao Xu
This network shows the impact of papers produced by Tao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Xu. The network helps show where Tao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 9 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 5 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 4 | |
| 13 | 2021 | 10 | |
| 14 | 2021 | 10 | |
| 15 | Clinical Applications of Cerebrospinal Fluid Circulating Tumor DNA as a Liquid Biopsy for Central Nervous System Tumors | 2020 | 2 |
| 16 | 2020 | 13 | |
| 17 | Effect of Shensong Yangxin capsule in combined with metroprolol succinate on the hemodynamics and heart rate variability in patients with arrhythmia of coronary heart disease | 2018 | 1 |
| 18 | TERT copy gain predicts the outcome of high-dose interferon α-2b therapy in acral melanoma | 2018 | 0 |
| 19 | 2014 | 4 | |
| 20 | 2013 | 7 |
About Tao Xu
Tao Xu is a scholar working on Cellular and Molecular Neuroscience, Physiology and Neurology, having authored 126 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (21 papers), Neuroscience and Neuropharmacology Research (13 papers), Ion channel regulation and function (9 papers), Neuropeptides and Animal Physiology (8 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Receptor Mechanisms and Signaling (5 papers), Musculoskeletal pain and rehabilitation (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (429 citations), Cellular and Molecular Neuroscience (276 citations) and Neurology (102 citations). Tao Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Weijun Xuan, Ying‐Ying Huang, Takahiro Ando, Michael R. Hamblin, Qiuhe Wu, Sulbha K. Sharma, Michael J. Whalen, Tianhong Dai, Liyi Huang and Heng‐Li Tian. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.